Literature DB >> 23007976

Knockdown expression of Apc11 leads to cell-cycle distribution reduction in G2/M phase.

Y-J Shi1, K-K Huo.   

Abstract

Anaphase-promoting complex/cyclosome (APC/C) is a key E3 ubiquitin ligase in cell division, which catalyses ubiquitination of cell-cycle regulators. Studying this complex could reveal important information regarding its application in cancer research and therapy. In this study, 4 synthesized small interfering RNAs (siRNAs) were transfected into HEK293T cells to suppress messenger RNA (mRNA) of Apc11; 2 of these reduced the amount of Apc11 mRNA by over 50%. Further experiments showed that rather than causing apoptosis, siRNA transfection led to cell-cycle distributions characterized by less time spent in G2/M phase and more time spent in G1 phase. This phenomenon was specifically induced by Apc11 silencing, as co-transfection of siRNA and an Apc11 plasmid could reverse this distribution bias. Our results suggested that siRNA targeted against Apc11 could hamper entry into G2/M phase. Current efforts are focused on elucidating the function and utility of the APC complex for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007976     DOI: 10.4238/2012.August.24.6

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  4 in total

1.  Overexpression of APC11 predicts worse survival in lung adenocarcinoma.

Authors:  Jiayu Zhou; Shizhen Zhang; Guoxiang Fu; Zhengfu He; Yong Xu; Weiwen Ye; Zhoumiao Chen
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

Review 2.  The role of long non-coding RNA BCAR4 in human cancers.

Authors:  Qiong Yi; Zhongcheng Liu; Kun Zhang; Xuening Liu; Lifu Wang; Bin Geng; Yayi Xia
Journal:  Hum Cell       Date:  2021-05-27       Impact factor: 4.174

3.  Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer.

Authors:  Youenn Drouet; Isabelle Treilleux; Alain Viari; Sophie Léon; Mojgan Devouassoux-Shisheboran; Nicolas Voirin; Christelle de la Fouchardière; Brigitte Manship; Alain Puisieux; Christine Lasset; Caroline Moyret-Lalle
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

4.  Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.

Authors:  A K M Nawshad Hossian; Md Sanaullah Sajib; Paul E Tullar; Constantinos M Mikelis; George Mattheolabakis
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.